There are 2789 resources available
695P - Drug-drug interactions between pazopanib and proton pump inhibitors may significantly affect clinical outcome of patients affected by metastatic renal cell carcinoma
Presenter: Marzia Del Re
Session: ePoster Display
635P - Association of ceramide metabolism with resistance to androgen receptor signalling inhibitors in metastatic prostate cancer
Presenter: Hui-Ming Lin
Session: ePoster Display
636P - A comparative analysis of prostate cancer short-term recurrence risk forecast performance between 8-gene signature and commercial panels
Presenter: Jinan Guo
Session: ePoster Display
638P - Evaluating the contribution of virtual peer-led support to comprehensive prostate cancer (PCa) care: The AnCan experience
Presenter: Herbert Geller
Session: ePoster Display
754P - Neoadjuvant chemotherapy followed by interval debulking surgery for advanced epithelial ovarian cancer in Japan - GOTIC-019: A multi-institutional retrospective cohort study
Presenter: Shoji Nagao
Session: ePoster Display
755P - A machine learning approach applied to gynaecological ultrasound to predict progression-free survival in ovarian cancer patients
Presenter: Francesca Arezzo
Session: ePoster Display
756P - Efficacy of circulating tumor DNA (ctDNA) analysis in the early detection of ovarian cancer progression
Presenter: Jinho Heo
Session: ePoster Display
757P - Investigation of PARP inhibitor resistance through the analysis of serially collected circulating tumor DNA (ctDNA) in ovarian cancer patients
Presenter: Yoo-Na Kim
Session: ePoster Display
758P - Concordance between multiple HRD assays is substantial in high-grade ovarian cancer
Presenter: Wilko Weichert
Session: ePoster Display